At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5 enrolled
Drug / intervention
Deep brain stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Tandem DBS for Parkinson's Disease: A Pilot Study Utilizing STN/GPi + Hypothalamic Stimulation
In Brief
A clinical study evaluating Deep brain stimulation for Parkinson's Disease and Deep Brain Stimulation. Completed, enrolled 5 participants across 1 site.
Detailed Summary
Does dual hemispheric stimulation of the subthalamic nucleus (STN) and fornix/hypothalamus potentially improve cognitive function in patients with Parkinsons disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson's Disease, Deep Brain Stimulation
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 2012
Enrollment StartApr 2012
Primary CompletionOct 2023
TodayJul 2026
First PostedMar 26, 2012
Enrollment StartApr 1, 2012
Primary CompletionOct 18, 2023
TodayJul 2, 2026
Enrollment to primary: 11.5 yearsPosted 14.3 years ago
Interventions
Deep brain stimulationdevice
Study will be utilizing multiple brain electrodes simultaneously. The study will require at least two electrodes to be placed in one cerebral hemisphere (one for motor improvement and one for potential cognitive implications).